Evidence map›Paper›PMID 37048828›Full record

ArticleJournal of clinical medicine2023

Ovarian Stimulation with FSH Alone versus FSH plus a GnRH Antagonist for Elective Freezing in an Oocyte Donor/Recipient Programme: A Protocol for a Pilot Multicenter Observational Study.

Ioannis E Messinis, Christina I Messini, Evangelos G Papanikolaou, Evangelos Makrakis, Dimitrios Loutradis, Nikolaos Christoforidis, Theodosis Arkoulis, Georgios Anifandis, Alexandros Daponte, Charalampos Siristatidis

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ioannis E MessinisDepartment of Obstetrics and Gynecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 415 00 Larissa, Greece.
Christina I MessiniDepartment of Obstetrics and Gynecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 415 00 Larissa, Greece.
Evangelos G PapanikolaouAssisting Nature IVF Unit, Giannou Kranidiotis, & Avenue 2, 570 01 Thessaloniki, Greece.
Evangelos MakrakisHYGEIA IVF EMBRYOGENESIS A.R.T. Unit, Fleming 15, 151 23 Athens, Greece.ORCID 0000-0002-6320-0494
Dimitrios LoutradisInstitute of Fertility, Pasteur 15, Mavili Square, 115 21 Athens, Greece.
Nikolaos ChristoforidisEmbryolab IVF Unit, Leoforos Ethnikis Antistaseos 175, 551 34 Thessaloniki, Greece.
Theodosis ArkoulisMitosis IVF Centre, Sachtouri 24, 185 37 Pireaus, Greece.
Georgios AnifandisDepartment of Obstetrics and Gynecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 415 00 Larissa, Greece.
Alexandros DaponteDepartment of Obstetrics and Gynecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 415 00 Larissa, Greece.ORCID 0000-0001-7300-9514
Charalampos SiristatidisAssisted Reproduction Unit, Second Department of Obstetrics and Gynecology, "Aretaieion" Hospital, Medical School, National and Kapodistrian University of Athens, 76 Vas. Sofias Av., 115 28 Athens, Greece.ORCID 0000-0003-0850-6623
University of Thessaly · GRAssisting Nature · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preliminary data have shown that it is possible to attempt in vitro fertilization (IVF) treatment in fresh cycles without the use of a gonadotropin-releasing hormone (GnRH) antagonist or any other medication to prevent the luteinizing hormone (LH) surge during ovarian stimulation. To date, there is no information on this topic in the context of a prospective controlled trial. However, as prevention of the LH surge is an established procedure in fresh cycles, the question is whether such a study can be performed in frozen cycles. We aim to perform a pilot study in order to compare the efficacy of a protocol using FSH alone with that of a protocol using follicle-stimulating hormone (FSH) plus a GnRH antagonist for controlled ovarian hyperstimulation (COH) in cycles of elective freezing in the context of a donor/recipient program. This is a seven-center, two-arm prospective pilot cohort study conducted at the respective Assisted Reproductive Units in Greece. The hypothesis to be tested is that an ovarian stimulation protocol that includes FSH alone without any LH surge prevention regimens is not inferior to a protocol including FSH plus a GnRH antagonist in terms of the clinical outcome in a donor/recipient model. The results of the present study are expected to show whether the addition of the GnRH antagonist is necessary in terms of the frequency of LH secretory peaks and progesterone elevations >1 ng/mL during the administration of the GnRH antagonist according to the adopted frequency of blood sampling in all Units.

Indexed as

assisted reproductive techniquesGnRH agonistGnRH antagonistin vitro fertilizationLH surgeoocyte donationovarian stimulation protocol

Identifiers

PMID37048828
PMCPMC10095010
OpenAlexW4362698815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.